These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 33172912)

  • 21. Factors Associated with Uptake of Genetics Services for Hypertrophic Cardiomyopathy.
    Khouzam A; Kwan A; Baxter S; Bernstein JA
    J Genet Couns; 2015 Oct; 24(5):797-809. PubMed ID: 25566741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A variant of unknown significance in the GLA gene causing diagnostic uncertainty in a young female with isolated hypertrophic cardiomyopathy.
    Al-Thihli K; Ebrahim H; Hughes DA; Patel M; Tipple M; Salvarinova R; Gardiner J; Vallance H; Waters PJ
    Gene; 2012 Apr; 497(2):320-2. PubMed ID: 22336178
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Results of clinical genetic testing of 2,912 probands with hypertrophic cardiomyopathy: expanded panels offer limited additional sensitivity.
    Alfares AA; Kelly MA; McDermott G; Funke BH; Lebo MS; Baxter SB; Shen J; McLaughlin HM; Clark EH; Babb LJ; Cox SW; DePalma SR; Ho CY; Seidman JG; Seidman CE; Rehm HL
    Genet Med; 2015 Nov; 17(11):880-8. PubMed ID: 25611685
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic screening of patients with hypertrophic cardiomyopathy--a new diagnostic strategy for risk stratification?
    Hudecova K; Simkova I; Gardlik R; Bernadic M
    Bratisl Lek Listy; 2009; 110(2):85-92. PubMed ID: 19408839
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel FHL1 mutation variant identified in a patient with nonobstructive hypertrophic cardiomyopathy and myopathy - a case report.
    Giucă A; Mitu C; Popescu BO; Bastian AE; Capşa R; Mursă A; Rădoi V; Popescu BA; Jurcuţ R
    BMC Med Genet; 2020 Sep; 21(1):188. PubMed ID: 32993534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular autopsy and family screening in a young case of sudden cardiac death reveals an unusually severe case of FHL1 related hypertrophic cardiomyopathy.
    Gaertner-Rommel A; Tiesmeier J; Jakob T; Strickmann B; Veit G; Bachmann-Mennenga B; Paluszkiewicz L; Klingel K; Schulz U; Laser KT; Karger B; Pfeiffer H; Milting H
    Mol Genet Genomic Med; 2019 Aug; 7(8):e841. PubMed ID: 31293105
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nonfamilial Hypertrophic Cardiomyopathy: Prevalence, Natural History, and Clinical Implications.
    Ingles J; Burns C; Bagnall RD; Lam L; Yeates L; Sarina T; Puranik R; Briffa T; Atherton JJ; Driscoll T; Semsarian C
    Circ Cardiovasc Genet; 2017 Apr; 10(2):. PubMed ID: 28408708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential contributions of sarcomere and mitochondria-related multigene variants to the endophenotype of hypertrophic cardiomyopathy.
    Chung H; Kim Y; Cho SM; Lee HJ; Park CH; Kim JY; Lee SH; Min PK; Yoon YW; Lee BK; Kim WS; Hong BK; Kim TH; Rim SJ; Kwon HM; Choi EY; Lee KA
    Mitochondrion; 2020 Jul; 53():48-56. PubMed ID: 32380161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comprehensive Genetic Testing for Pediatric Hypertrophic Cardiomyopathy Reveals Clinical Management Opportunities and Syndromic Conditions.
    Gal DB; Morales A; Rojahn S; Callis T; Garcia J; Priest JR; Truty R; Vatta M; Nussbaum RL; Esplin ED; Hollander SA
    Pediatr Cardiol; 2022 Mar; 43(3):616-623. PubMed ID: 34714385
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RNA Splicing Defects in Hypertrophic Cardiomyopathy: Implications for Diagnosis and Therapy.
    Ribeiro M; Furtado M; Martins S; Carvalho T; Carmo-Fonseca M
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32079122
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Penetrance of Hypertrophic Cardiomyopathy in Sarcomere Protein Mutation Carriers.
    Lorenzini M; Norrish G; Field E; Ochoa JP; Cicerchia M; Akhtar MM; Syrris P; Lopes LR; Kaski JP; Elliott PM
    J Am Coll Cardiol; 2020 Aug; 76(5):550-559. PubMed ID: 32731933
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic considerations in hypertrophic cardiomyopathy.
    Ho CY
    Prog Cardiovasc Dis; 2012; 54(6):456-60. PubMed ID: 22687586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The uptake of family screening in hypertrophic cardiomyopathy and an online video intervention to facilitate family communication.
    Harris S; Cirino AL; Carr CW; Tafessu HM; Parmar S; Greenberg JO; Szent-Gyorgyi LE; Ghazinouri R; Glowny MG; McNeil K; Kaynor EF; Neumann C; Seidman CE; MacRae CA; Ho CY; Lakdawala NK
    Mol Genet Genomic Med; 2019 Nov; 7(11):e940. PubMed ID: 31482667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of centre expertise on the diagnosis and management of hypertrophic cardiomyopathy: A study from the French register of hypertrophic cardiomyopathy (REMY).
    Mirabel M; Damy T; Donal E; Huttin O; Labombarda F; Eicher JC; Cervino C; Laurito M; Offredo L; Tafflet M; Jouven X; Giura G; Desnos M; Jeunemaître X; Empana JP; Charron P; Habib G; Réant P; Hagège A;
    Int J Cardiol; 2019 Jan; 275():107-113. PubMed ID: 30316646
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Potential Oligogenic Etiology of Hypertrophic Cardiomyopathy: A Classic Single-Gene Disorder.
    Li L; Bainbridge MN; Tan Y; Willerson JT; Marian AJ
    Circ Res; 2017 Mar; 120(7):1084-1090. PubMed ID: 28223422
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic testing in patients with hypertrophic cardiomyopathy.
    Bonaventura J; Veselka J
    Vnitr Lek; 2019; 65(10):652-658. PubMed ID: 31906687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comprehensive Versus Targeted Genetic Testing in Children with Hypertrophic Cardiomyopathy.
    Bales ND; Johnson NM; Judge DP; Murphy AM
    Pediatr Cardiol; 2016 Jun; 37(5):845-51. PubMed ID: 26936621
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new era in clinical genetic testing for hypertrophic cardiomyopathy.
    Wheeler M; Pavlovic A; DeGoma E; Salisbury H; Brown C; Ashley EA
    J Cardiovasc Transl Res; 2009 Dec; 2(4):381-91. PubMed ID: 20559996
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Yield of Clinical Screening for Hypertrophic Cardiomyopathy in Child First-Degree Relatives.
    Norrish G; Jager J; Field E; Quinn E; Fell H; Lord E; Cicerchia MN; Ochoa JP; Cervi E; Elliott PM; Kaski JP
    Circulation; 2019 Jul; 140(3):184-192. PubMed ID: 31006259
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical spectrum of preclinical hypertrophic cardiomyopathy: characterizing carriers of sarcomere gene mutation].
    Ho CY
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Apr; 37(4):289-93. PubMed ID: 19791460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.